Lower Drug Costs for Families Act

This bill extends Medicare drug rebate rules to private health insurance. Currently, drug companies must pay rebates to Medicare for brand-name drugs without generic versions that cost $100 or more per year and have price increases above inflation rates. The bill would apply these same rebate requirements to prescription drugs covered by private insurance plans. It also changes how rebates are calculated by using 2016 drug prices instead of 2021 prices as the starting point.

Your Vote